{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:22:35Z","timestamp":1788355355669,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00467-023-06110-w","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T09:02:07Z","timestamp":1691053327000},"page":"261-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lipid abnormalities in pediatric kidney transplant recipients on steroid withdrawal maintenance immunosuppression"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6647-2930","authenticated-orcid":false,"given":"Emily","family":"Zangla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4580-7073","authenticated-orcid":false,"given":"Ruchi","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5824-7856","authenticated-orcid":false,"given":"Sarah J.","family":"Kizilbash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"key":"6110_CR1","doi-asserted-by":"publisher","first-page":"e12914","DOI":"10.1111\/petr.12914","volume":"21","author":"S Habbig","year":"2017","unstructured":"Habbig S, Volland R, Krupka K, Querfeld U, Dello Strologo L, Noyan A, Yalcinkaya F, Topaloglu R, Webb NJ, Kemper MJ, Pape L, Bald M, Kranz B, Taylan C, H\u00f6cker B, T\u00f6nshoff B, Weber LT (2017) Dyslipidemia after pediatric renal transplantation - the impact of immunosuppressive regimens. Pediatr Transplant 21:e12914. https:\/\/doi.org\/10.1111\/petr.12914","journal-title":"Pediatr Transplant"},{"key":"6110_CR2","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1399-3046.2005.00373.x","volume":"9","author":"L Butani","year":"2005","unstructured":"Butani L (2005) Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation. Pediatr Transplant 9:746\u2013753. https:\/\/doi.org\/10.1111\/j.1399-3046.2005.00373.x","journal-title":"Pediatr Transplant"},{"key":"6110_CR3","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/s0041-1345(01)01915-7","volume":"33","author":"A Delucchi","year":"2001","unstructured":"Delucchi A, Mar\u00edn V, Trabucco G, Az\u00f3car M, Salas P, Gutierrez E, Guardia S, Cano F, Cumsille MA (2001) Dyslipidemia and dietary modification in Chilean renal pediatric transplantation. Transplant Proc 33:1297\u20131301. https:\/\/doi.org\/10.1016\/s0041-1345(01)01915-7","journal-title":"Transplant Proc"},{"key":"6110_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00467-003-1136-y","volume":"18","author":"BM Chavers","year":"2003","unstructured":"Chavers BM, H\u00e5rdstedt M, Gillingham KJ (2003) Hyperlipidemia in pediatric kidney transplant recipients treated with cyclosporine. Pediatr Nephrol 18:565\u2013569. https:\/\/doi.org\/10.1007\/s00467-003-1136-y","journal-title":"Pediatr Nephrol"},{"key":"6110_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00147-003-0677-0","volume":"17","author":"A Siirtola","year":"2004","unstructured":"Siirtola A, Antikainen M, Ala-Houhala M, Koivisto AM, Solakivi T, Jokel H, Lehtim\u00e4ki T, Holmberg C, Salo MK (2004) Serum lipids in children 3 to 5 years after kidney, liver, and heart transplantation. Transpl Int 17:109\u2013119. https:\/\/doi.org\/10.1007\/s00147-003-0677-0","journal-title":"Transpl Int"},{"key":"6110_CR6","doi-asserted-by":"publisher","first-page":"981838","DOI":"10.3389\/fcvm.2022.981838","volume":"9","author":"A Elezaby","year":"2022","unstructured":"Elezaby A, Dexheimer R, Sallam K (2022) Cardiovascular effects of immunosuppression agents. Front Cardiovasc Med 9:981838. https:\/\/doi.org\/10.3389\/fcvm.2022.981838","journal-title":"Front Cardiovasc Med"},{"key":"6110_CR7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1681\/ASN.V122368","volume":"12","author":"G Ligtenberg","year":"2001","unstructured":"Ligtenberg G, Hen\u00e9 RJ, Blankestijn PJ, Koomans HA (2001) Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus. J Am Soc Nephrol 12:368\u2013373. https:\/\/doi.org\/10.1681\/ASN.V122368","journal-title":"J Am Soc Nephrol"},{"key":"6110_CR8","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1111\/j.1600-6143.2005.01105","volume":"5","author":"H Holdaas","year":"2005","unstructured":"Holdaas H, Fellstr\u00f6m B, Cole E, Nyberg G, Olsson AG, Pedersen TR, Madsen S, Gr\u00f6nhagen-Riska C, Neumayer HH, Maes B, Amb\u00fchl P, Hartmann A, Staffler B, Jardine AG, Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators (2005) Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study. Am J Transplant 5:2929\u20132936. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01105","journal-title":"Am J Transplant"},{"key":"6110_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1034\/j.1399-3046.2003.02048","volume":"7","author":"E Argent","year":"2003","unstructured":"Argent E, Kainer G, Aitken M, Rosenberg AR, Mackie FE (2003) Atorvastatin treatment for hyperlipidemia in pediatric renal transplant recipients. Pediatr Transplant 7:38\u201342. https:\/\/doi.org\/10.1034\/j.1399-3046.2003.02048","journal-title":"Pediatr Transplant"},{"key":"6110_CR10","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ki.2014.31","volume":"85","author":"C Wanner","year":"2014","unstructured":"Wanner C, Tonelli M, Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members (2014) KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int 85:1303\u20131309. https:\/\/doi.org\/10.1038\/ki.2014.31","journal-title":"Kidney Int"},{"key":"6110_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5500\/wjt.v6.i1.125","volume":"6","author":"A Agarwal","year":"2016","unstructured":"Agarwal A, Prasad GV (2016) Post-transplant dyslipidemia: mechanisms, diagnosis and management. World J Transplant 6:125\u2013134. https:\/\/doi.org\/10.5500\/wjt.v6.i1.125","journal-title":"World J Transplant"},{"key":"6110_CR12","unstructured":"Boston Children\u2019s Hospital Heart Center (2023) BCH Z-score calculator. https:\/\/zscore.chboston.org\/Home\/About. Accessed 19 June 2023"},{"key":"6110_CR13","unstructured":"Chronic Kidney Disease in Children Study (2021) CKiD calculators. https:\/\/statepi.jhsph.edu\/ckid\/investigator-resources\/ckid-calculators\/. Accessed 19 June 2023"},{"key":"6110_CR14","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1542\/peds.2009-2107C","volume":"128","author":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute","year":"2011","unstructured":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute (2011) Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128:S213\u2013S256. https:\/\/doi.org\/10.1542\/peds.2009-2107C","journal-title":"Pediatrics"},{"key":"6110_CR15","doi-asserted-by":"publisher","first-page":"e14189","DOI":"10.1111\/petr.14189","volume":"26","author":"SJ Kizilbash","year":"2022","unstructured":"Kizilbash SJ, Jensen CJ, Kouri A, Balani SS, Chavers B (2022) Steroid avoidance\/withdrawal and maintenance immunosuppression in pediatric kidney transplantation. Pediatr Transplant 26:e14189. https:\/\/doi.org\/10.1111\/petr.14189","journal-title":"Pediatr Transplant"},{"key":"6110_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00467-019-04428-y","volume":"36","author":"ME Bock","year":"2021","unstructured":"Bock ME, Wall L, Dobrec C, Chandran M, Goebel J (2021) Management of dyslipidemia in pediatric renal transplant recipients. Pediatr Nephrol 36:51\u201363. https:\/\/doi.org\/10.1007\/s00467-019-04428-y","journal-title":"Pediatr Nephrol"},{"key":"6110_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/CIRCULATIONAHA.107.718981","volume":"117","author":"CG Magnussen","year":"2008","unstructured":"Magnussen CG, Raitakari OT, Thomson R, Juonala M, Patel DA, Viikari JS, Marniemi J, Srinivasan SR, Berenson GS, Dwyer T, Venn A (2008) Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study. Circ 117:32\u201342. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.718981","journal-title":"Circ"},{"key":"6110_CR18","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/s0025-6196(12)64916-7","volume":"63","author":"PC de Groen","year":"1988","unstructured":"de Groen PC (1988) Cyclosporine, low-density lipoprotein, and cholesterol. Mayo Clin Proc 63:1012\u20131021. https:\/\/doi.org\/10.1016\/s0025-6196(12)64916-7","journal-title":"Mayo Clin Proc"},{"key":"6110_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","volume":"115","author":"N Sarwar","year":"2007","unstructured":"Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V (2007) Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circ 115:450\u2013458. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.637793","journal-title":"Circ"},{"key":"6110_CR20","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/ki.2010.311","volume":"78","author":"JM Saland","year":"2010","unstructured":"Saland JM, Pierce CB, Mitsnefes MM, Flynn JT, Goebel J, Kupferman JC, Warady BA, Furth SL, CKiD Investigators (2010) Dyslipidemia in children with chronic kidney disease. Kidney Int 78:1154\u20131163. https:\/\/doi.org\/10.1038\/ki.2010.311","journal-title":"Kidney Int"},{"key":"6110_CR21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1210\/jcem.86.3.7304","volume":"86","author":"IJ Goldberg","year":"2001","unstructured":"Goldberg IJ (2001) Clinical review 124: diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab 86:965\u2013971","journal-title":"J Clin Endocrinol Metab"},{"key":"6110_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/petr.12174","volume":"18","author":"M Kaidar","year":"2014","unstructured":"Kaidar M, Berant M, Krauze I, Cleper R, Mor E, Bar-Nathan N, Davidovits M (2014) Cardiovascular risk factors in children after kidney transplantation\u2013from short-term to long-term follow-up. Pediatr Tansplant 18:23\u201328. https:\/\/doi.org\/10.1111\/petr.12174","journal-title":"Pediatr Tansplant"},{"key":"6110_CR23","doi-asserted-by":"publisher","first-page":"e603","DOI":"10.1161\/CIR.0000000000000618","volume":"139","author":"SD de Ferranti","year":"2019","unstructured":"de Ferranti SD, Steinberger J, Ameduri R, Baker A, Gooding H, Kelly AS, Mietus-Snyder M, Mitsnefes MM, Peterson AL, St-Pierre J, Urbina EM, Zachariah JP, Zaidi AN (2019) Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association. Circ 139:e603\u2013e634. https:\/\/doi.org\/10.1161\/CIR.0000000000000618","journal-title":"Circ"},{"key":"6110_CR24","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1161\/01.cir.0000035247.42888.82","volume":"106","author":"S de Jongh","year":"2002","unstructured":"de Jongh S, Ose L, Szamosi T, Gagn\u00e9 C, Lambert M, Scott R, Perron P, Dobbelaere D, Saborio M, Tuohy MB, Stepanavage M, Sapre A, Gumbiner B, Mercuri M, van Trotsenburg AS, Bakker HD, Kastelein JJ, Simvastatin in Children Study Group (2002) Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circ 106:2231\u20132237. https:\/\/doi.org\/10.1161\/01.cir.0000035247.42888.82","journal-title":"Circ"},{"key":"6110_CR25","doi-asserted-by":"publisher","first-page":"CD00640","DOI":"10.1002\/14651858.CD006401.pub5","volume":"2019","author":"A Vuorio","year":"2019","unstructured":"Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E, Ramaswami U (2019) Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev 2019:CD00640. https:\/\/doi.org\/10.1002\/14651858.CD006401.pub5","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06110-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-023-06110-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06110-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T11:06:59Z","timestamp":1700824019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-023-06110-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6110"],"URL":"https:\/\/doi.org\/10.1007\/s00467-023-06110-w","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}